Calling into question the future of hyperoxygenation in pregnancy

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Neonatal Physiology

Background:

• Maternal hyperoxygenation has been explored for decades as a diagnostic and therapeutic intervention in obstetrics.
• Its application often occurs without baseline maternal or fetal oxygenation assessment.
• Long-term studies on its efficacy for fetal growth restriction show no clear benefits.

Purpose of the Study:

• To review the effects of maternal hyperoxygenation on both maternal and fetal health.
• To evaluate the safety of conducting future clinical trials involving maternal hyperoxygenation during pregnancy.

Main Methods:

• Literature review of studies on maternal hyperoxygenation in obstetric scenarios.
• Analysis of research concerning its use in fetal growth restriction and congenital cardiac disease.
• Assessment of reported maternal and fetal outcomes and adverse effects.

Main Results:

• No clear evidence of benefit from maternal oxygen therapy for fetal growth restriction over thirty years of research.
• Variable success rates and concerning adverse effects reported for fetal congenital cardiac disease.
• Current data is insufficient to definitively establish safety for widespread clinical application.

Conclusions:

• The efficacy of maternal hyperoxygenation remains uncertain for key obstetric conditions.
• Potential adverse effects necessitate caution regarding its use.
• Further rigorous investigation is required to ascertain safety before broader clinical trials.